Massachusetts Financial Services
KALV

Massachusetts Financial Services’s KalVista Pharmaceuticals KALV Stock Holding History

Massachusetts Financial Services’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,254
Closed -$545K – 914
2021
Q3 		$545K Sell
31,254
-12,332
-28% -$250K ﹤0.01% 869
2021
Q2 		$1.04M Buy
43,586
+29,829
+217% +$780K ﹤0.01% 838
2021
Q1 		$353K Buy
+13,757
New +$361K ﹤0.01% 894

Other funds holding KALV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services's KALV Position: Q4 2021 in Review

Massachusetts Financial Services sold out of KalVista Pharmaceuticals (KALV) in Q4 2021, closing a stake of 31,254 shares — an estimated $545K sold.

Massachusetts Financial Services first reported a position in KALV in Q1 2021 and held it in 3 quarters. The position peaked at $1.04M in Q2 2021. 97 funds tracked by Wall St. Rank hold KALV as of Q4 2021.

  • Massachusetts Financial Services reported no remaining KalVista Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 31,254 KalVista Pharmaceuticals shares in Q4 2021, an estimated $545K.
  • Massachusetts Financial Services first reported a position in KalVista Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Massachusetts Financial Services's KalVista Pharmaceuticals position peaked at $1.04M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2021.

Based on Massachusetts Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.